The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Ofranergene obadenovec (VB-111) in platinum resistant ovarian cancer: with an immunotherapeutic effect.
 
Yael Chava Cohen
Employment - VBL Therapeutics
Leadership - VBL Therapeutics
Stock and Other Ownership Interests - VBL Therapeutics
Honoraria - Janssen; Medison; NeoPharm; Takeda
Consulting or Advisory Role - Medison; Takeda
Research Funding - Amgen
Patents, Royalties, Other Intellectual Property - VBL Therapeutics
 
Suzanne T. Berlin
No Relationships to Disclose
 
Michael J. Birrer
Consulting or Advisory Role - Acceleron Pharma; AstraZeneca; Clovis Oncology; Immunogen; Immunogen; Merrimack; Oxigene; Roche/Genentech; Sanofi; Tesaro; Threshold Pharmaceuticals
 
Susana M. Campos
Consulting or Advisory Role - Clovis Oncology
 
Tamar Rachmilewitz Minei
Employment - VBL Therapeutics
Leadership - VBI Vaccines
Stock and Other Ownership Interests - VBL Therapeutics
 
Dror Harats
Employment - VBL Therapeutics
Leadership - VBL Therapeutics
Stock and Other Ownership Interests - VBL Therapeutics
Patents, Royalties, Other Intellectual Property - VBL Therapeutics
Travel, Accommodations, Expenses - VBL Therapeutics
 
Richard T. Penson
Honoraria - Abbvie; Amgen; AstraZeneca; Baxalta; Clovis Oncology; Eisai; Genentech; Merck; Mersana; Sutter Medical Group; Tesaro; Vascular Biogenics
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; Baxalta; Care4ward; Clovis Oncology; Eisai; Genentech; Merck; Mersana; Sutter Medical Group; Tesaro; Vascular Biogenics
Research Funding - Array BioPharma (Inst); AstraZeneca (Inst); Cerulean Pharma (Inst); Eisai (Inst); Genentech (Inst); Regeneron (Inst); Sanofi (Inst); Tesaro (Inst); Vascular Biogenics (Inst)
Patents, Royalties, Other Intellectual Property - Blackwell Publishing; BMJ; UpToDate
Travel, Accommodations, Expenses - AstraZeneca; Clovis Oncology; Genentech; Tesaro; Vascular Biogenics
Other Relationship - Abbvie